Cell therapy weekly: Kymriah could be available in Japan and stem cells show benefits against multiple sclerosis
This week: Stem cells superior to drugs against multiple sclerosis, Cynata completes Cymerus™ patent application and extracellular vesicles could work 'off the shelf'.
Please sign in or register for FREE
Sign in to RegMedNet
Register to RegMedNet
RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.